You are here
Traffic‐related air pollution, lipoproteins, and cardiovascular disease risk in the VITamin D and OmegA‐3 TriaL (VITAL)
This project will leverage an existing randomized control trial of older individuals in the United States to examine the associations of exposure to traffic-related air pollution and incident cardiovascular disease events and biomarkers of cardiovascular health. The investigators will also explore the potential for vitamin D and omega-fatty acid supplementation to modify the associations.
Background and objectives: Multiple pathways have linked air pollution with cardiovascular disease (CVD), the leading cause of death in the U.S. and globally. We are examining both cross-sectional and longitudinal associations of traffic related air pollution (TRAP) with incident CVD (including coronary heart disease [CHD] and stroke) events and exploring potential mediating lipid pathways of risk in the study population of the VITamin D and OmegA-3 TriaL (VITAL), a double-blind, placebo-controlled clinical trial of vitamin D and marine omega-3 fatty acid supplements in the primary prevention of cancer and CVD.
Methods and approach: We use satellite-based small-scale (≤1 km) exposure models to estimate daily residence-specific ambient nitrogen dioxide (NO2), particulate matter <2.5 µm (PM2.5), and 11 tailpipe and non-tailpipe source PM2.5 components. Cox proportional hazards models, stratified by sex, age, and randomization year, are fitted to estimate associations of long-term exposure with CVD outcomes. Results are presented as hazard ratios (HR) per interquartile (IQR) increase in exposure, adjusted for BMI and smoking.
Results and findings: During follow-up (5 years of intervention plus 6 years post-intervention, ongoing), a total of 2,314 CVD events occurred (1,111 CHD and 523 strokes) among 25,747 study participants with residence in the contiguous U.S. (50.6 % women, 69.7 % White, 19.8 % Black, mean baseline age 67.1 yrs). Average annual exposure before randomization was 19.6 ppb NO2 and 9.0 µg/m3 PM2.5.
NO2 and total PM2.5 mass were not associated with CVD or CHD. By contrast, PM2.5 components calcium (Ca), potassium (K), and silicon (Si) were associated with increased risk of CHD (Ca: HR=1.08 [1.03-1.14]; K: HR=1.10 [1.03-1.17]; Si: HR=1.07 [1.02-1.14]). Associations with total CVD had a similar pattern but were weaker.
Conclusions and interpretations: Exposure to several markers for local non-tailpipe traffic was associated with increased long-term risk of CHD and CVD in the VITAL study population.

